カリフォルニア州におけるリンパ腫の臨床試験
カリフォルニア州内の拠点で、リンパ腫に関する40件の研究が参加者を募集しています。
カリフォルニア州内の都市
- Baldwin Park21件の研究
- Los Angeles10件の研究
- Mountain View9件の研究
- San Francisco6件の研究
- San Diego6件の研究
- Santa Monica4件の研究
- Orange4件の研究
公式研究テキスト（英語）
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
- University of California, Davis, Sacramento
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06343311A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- City of Hope, Duarte
- University of California, Irvine Medical Center - Hematology/Oncology, Orange
- Stanford University School of Medicine, Stanford
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07192471Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone Lymphoma
- City of Hope Medical Center, Duarte
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07583810A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Children's Hospital Los Angeles, Los Angeles
- University of California at Los Angeles, Los Angeles
被験者募集中第1/2相
25歳以下 · 全性別 · 2026/09/25更新 · NCT04094610Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
- UCSF Benioff Children's Hospital, San Francisco
被験者募集中第1相
24 Months – 18 Years · 全性別 · 2026/09/25更新 · NCT06441331A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
- City of Hope, Duarte
- Cedars-Sinai Medical Center, Los Angeles
- Scripps Health, San Diego
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07221500Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
- City of Hope, Duarte
被験者募集中第1相
18歳〜100歳 · 全性別 · 2026/09/15更新 · NCT05798897AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
- Research Site, Duarte
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/09/14更新 · NCT06137144CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- Children's Hospital Los Angeles, Los Angeles
- Children's Hospital of Orange County, Orange
- UCSF Medical Center-Mission Bay, San Francisco
被験者募集中第1/2相
12 Months – 21 Years · 全性別 · 2026/09/11更新 · NCT04870944Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
- Research Site, La Jolla
被験者募集中第3相
18歳〜18歳 · 全性別 · 2026/09/08更新 · NCT07509151A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- Saddleback Memorial Medical Center, Laguna Hills
- Hoag Memorial Hospital, Newport Beach
- University of California Los Angeles (UCLA) - Cancer Care - Santa Monica, Santa Monica
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06624085TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas
- Stanford Medicine Cancer Center, Palo Alto
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/04更新 · NCT07082803A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
- City of Hope Cancer Center, Duarte
- Valkyrie Clinical Trials, Los Angeles
- University of California Los Angeles (UCLA) - Cancer Care - Santa Monica, Santa Monica
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/03更新 · NCT06084936Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
- City of Hope National Medical Center, Duarte
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/09/03更新 · NCT04588922Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
- Children s Hospital of Los Angeles, Los Angeles
被験者募集中観察研究健康なボランティア歓迎
5歳以上 · 全性別 · 2026/08/31更新 · NCT05237986Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- University of California-Irvine Medical Center, Irvine
- Cedars-Sinai Medical Center, Los Angeles
- University of California, Los Angeles (UCLA) Medical Center, Los Angeles
- 他1件
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/25更新 · NCT05826535A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
- City of Hope, Duarte
- Sarcoma Oncology Research Center, Santa Monica
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/08/20更新 · NCT06678659A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
- City of Hope, Duarte
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/17更新 · NCT06528301AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas
- Stanford University, Palo Alto
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/12更新 · NCT06340737Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
- City of Hope, Duarte
- Valkyrie Clinical Trials, Los Angeles
被験者募集中第1/2相
13歳〜90歳 · 全性別 · 2026/08/06更新 · NCT06533579A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
- Cedars-Sinai Medical Center, Los Angeles
- University of California, Los Angeles (UCLA), Los Angeles
- University of California, Irvine, Orange
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/04更新 · NCT07188558Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
被験者募集中早期第1相
18歳以上 · 全性別 · 2026/07/31更新 · NCT07628634DALY II USA/ MB-CART2019.1 for DLBCL
- UC San Diego Health, La Jolla
- Stanford University, Stanford
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/13更新 · NCT04792489A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
- City of Hope, Duarte
- University of California, San Francisco, San Francisco
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/02更新 · NCT05131022A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
- Dren Investigational Site, Duarte
- Dren Investigational Site, Irvine
- Dren Investigational Site, Redwood City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/17更新 · NCT05475925Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
- UC San Diego Moores Cancer Center, La Jolla
- University of California, San Francisco, San Francisco
被験者募集中観察研究
18歳以上 · 全性別 · 2026/06/01更新 · NCT05663502Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)
- Stanford Medical Center, Stanford
被験者募集中第2相
15歳以上 · 全性別 · 2026/05/27更新 · NCT06954805Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- City of Hope Comprehensive Cancer Center, Duarte
- Kaiser Permanente-Oakland, Oakland
- Lucile Packard Children's Hospital Stanford University, Palo Alto
- 他1件
被験者募集中観察研究
全年齢 · 全性別 · 2026/05/18更新 · NCT01790152CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- City of Hope, Duarte
- Providence St. John's Health Center, Santa Monica
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/16更新 · NCT03328078The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
- City of Hope, Duarte
- Los Angeles Cancer Network, Los Angeles
- UCLA Medical Center of Hematology/Oncology, Los Angeles
- 他1件
被験者募集中第1/2相
12歳〜95歳 · 全性別 · 2026/04/15更新 · NCT04329728A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma
- City of Hope National Medical Center, Duarte
被験者募集中第2相
18歳以上 · 全性別 · 2026/03/27更新 · NCT06915246A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
- City of Hope, Duarte
被験者募集中第1相
18歳以上 · 全性別 · 2026/03/20更新 · NCT04830137A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- City of Hope, Duarte
- Stanford, Palo Alto
被験者募集中第2相
18歳〜66歳 · 全性別 · 2026/03/17更新 · NCT06859424Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy
- Stanford, Stanford
被験者募集中第2相
18歳以上 · 全性別 · 2026/03/13更新 · NCT06510361Pediatric PET/MR Image Registry
- Stanford University, School of Medicine, Palo Alto
被験者募集中観察研究
40歳以下 · 全性別 · 2026/02/09更新 · NCT03458520Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)
- City of Hope Medical Center, Duarte
被験者募集中第1相
18歳以上 · 全性別 · 2026/01/28更新 · NCT05371132cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- City of Hope, Duarte
被験者募集中観察研究健康なボランティア歓迎
40歳以上 · 全性別 · 2026/01/20更新 · NCT05366881Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial
- Kaiser Permanente-Fremont, Fremont
- Kaiser Permanente-San Francisco, San Francisco
被験者募集中第3相健康なボランティア歓迎
18歳以上 · 全性別 · 2026/01/13更新 · NCT05006482A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
- San Francisco VA Medical Center, San Francisco, CA, San Francisco
被験者募集中第2相
18歳〜80歳 · 全性別 · 2025/10/14更新 · NCT06520098Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
- City of Hope Medical Foundation, Duarte
- University of Southern California, Los Angeles
被験者募集中第1相
18歳以上 · 全性別 · 2025/09/22更新 · NCT04234048ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。